SDC4 and angina pectoris: Vascular endothelial cells under hypoxic conditions, such as those during angina, might promote syndecan-4 synthesis to prevent vascular occlusion by reinforcing anticoagulant activity, which is partly due to the activation of antithrombin III by heparan-sulfate chains associated with syndecan-4 in the vascular endothelium.